Frequently Asked Questions
The market is segmented based on , By Product (Lateral Flow Assays, Dipsticks, and Paper-Based Microfluidics), Device Type (Diagnostic Devices, and Monitoring Devices), Application (Clinical Diagnostics, Food Quality Testing, and Environmental Monitoring), End-Use (Home Healthcare, Assisted Living Healthcare Facilities, Hospital and Clinics) – Industry Trends and Forecast to 2031.
.
The Global Paper Diagnostics Market size was valued at USD 17.62 USD Billion in 2023.
The Global Paper Diagnostics Market is projected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2031.
The major players operating in the market include ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), Abbott (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GVS S.p.A (Italy), Siemens (Germany), Diagnostics for All, Inc. (U.S.), FFEI (U.K.), Navigene (India), Micro Essential Laboratory Inc. (U.S.), Medlife International Pvt. Ltd. (India), Kenosha Tapes (U.S.), Abcam plc (U.K.), Abingdon Health (U.K.), Chembio Diagnostic Systems, Inc. (U.S.), Cytodiagnostics Inc. (Canada), DCN Diagnostics (U.S.), NanoHybrids (U.S.), Merck KGaA (Germany), Surmodics, Inc. (U.S.).
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.
